| 000 | 01140 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517134317.0 | ||
| 264 | 0 | _c20170502 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1179-1950 | ||
| 024 | 7 |
_a10.1007/s40265-017-0690-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHay, Kevin A | |
| 245 | 0 | 0 |
_aChimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies. _h[electronic resource] |
| 260 |
_bDrugs _cMar 2017 |
||
| 300 |
_a237-245 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntigens, CD19 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 |
_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aTurtle, Cameron J | |
| 773 | 0 |
_tDrugs _gvol. 77 _gno. 3 _gp. 237-245 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40265-017-0690-8 _zAvailable from publisher's website |
| 999 |
_c26806583 _d26806583 |
||